UniProtKB/Swiss-Prot Q9UBC1: Variant p.Arg224Cys

NF-kappa-B inhibitor-like protein 1
Gene: NFKBIL1
Feedback?

Variant information Variant position:

224 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Cysteine (C) at position 224 (R224C, p.Arg224Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Arg-224 is found in the MHC 7.1 haplotype (HLA-A3,B7,DR15) population. Additional information on the polymorphism described.
Other resources:

Links to websites of interest for the variant.

Variant rs3130062 [ dbSNP | Ensembl ]

Sequence information Variant position:

224 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

381 The length of the canonical sequence.
Location on the sequence:

RLAREHAQKCQQQQREAEGS R RPPRAEGSSQSWRQQEEEQR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RLAREHAQKCQQQQREAEGSRRPPRAEGSSQSWRQQEEEQR

Rhesus macaque                RLAREHAQKCQQQQREAEGSCRPPRAEGSSQSWRQQEEEQR

Chimpanzee                    RLAREHAQKYQQQQREAEGSCRPPRAEGSSQSWRQQEEEQR

Mouse                         RLAREHAQKQ-RQQLEAEGSCRPPRAEGSSHSWRQHEEEQR

Rat                           RLAREHAQKQRRQQLEAEGSRRPPRAEGSSHSWRQQEEEQR

Pig                           RMAREHAQKR-QQQRETEGACRPPRAEGSSHSWRQQEEEQR

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 381	NF-kappa-B inhibitor-like protein 1
Region	186 – 294	Disordered
Compositional bias	201 – 226	Basic and acidic residues

Literature citations
Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins.
Albertella M.R.; Campbell D.R.;
Hum. Mol. Genet. 3:793-799(1994)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT CYS-224; The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15.
Allcock R.J.N.; Christiansen F.T.; Price P.;
Immunogenetics 49:660-665(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT CYS-224;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.